An approach to the toxicity and toxicokinetics of aflatoxin B1 and ochratoxin A after simultaneous oral administration to fasted F344 rats

Food and Chemical Toxicology

Volumn 50, Issue 10, 2012, Pages 3440-3446

  Corcuera, L A ^a   Vettorazzi, A ^a   Arbillaga, L ^a   Gonzalez Penas E ^a   Lopez de Cerain A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Aflatoxin B1; Ochratoxin A; Simultaneous administration; Toxicity; Toxicokinetic

Indexed keywords

AFLATOXIN B1; OCHRATOXIN;

ABSORPTION; ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD LEVEL; CHEMICAL ANALYSIS; FISCHER 344 RAT; HISTOPATHOLOGY; KIDNEY; LIVER; LIVER TOXICITY; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLISM; NONHUMAN; RAT; TOXICOKINETICS; TOXICOLOGICAL PARAMETERS;

ADMINISTRATION, ORAL; AFLATOXIN B1; ANIMALS; HALF-LIFE; KIDNEY; LIVER; MALE; OCHRATOXINS; ORGAN SIZE; RANDOM ALLOCATION; RATS; RATS, INBRED F344;

RATTUS;

EID: 84865488373     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.06.048     Document Type: Article

References (60)

1. Arbillaga L., Azqueta A., Ezpeleta O., Lopez de Cerain A. Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: evidence of the relationship with cytotoxicity. Mutagenesis 2007, 22:35-42.
2. Arbillaga L., Ezpeleta O., Lopez de Cerain A. ¿Es la Ocratoxina A una micotoxina mutagénica? (Is the Ochratoxin A a mutagenic mycotoxine?). Revista de Toxicología 2004, 21:1-10.
3. Bannasch P., Benner U., Enzmann H., Hacker H.J. Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1. Carcinogenesis 1985, 6:1641-1648.
4. Bedard L.L., Massey T.E. Aflatoxin B1-induced DNA damage and its repair. Cancer Lett. 2006, 241:174-183.
5. Bennett J.W., Klich M. Mycotoxins. Clin. Microbiol. Rev. 2003, 16:497-516.
6. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Steve J., Steinmann J., Tillmann T., Michelon J., Bartsch H. Sex- and strainspecific induction of renal tumor by ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer 1998, 77:70-75.
7. Corcuera L.A., Ibáñez-Vea M., Vettorazzi A., González-Peñas E.López de Cerain, A. Validation of a UHPLC-FLD analytical method for the simultaneous quantification of aflatoxin B1 and ochratoxin a in rat plasma, liver and kidney. J. Chromatogr. B 2011, 879:2733-2740.
8. Coulombe R.A., Sharma R.P. Clearance and excretion of intratracheally and orally administered aflatoxin B1 in the rat. Food Chem. Toxicol. 1985, 23:827-830.
9. Cupid B.C., Lightfoot T.J., Russell D., Gant S.J., Turner P.C., Dingley K.H., Curtis K.D., Leveson S.H., Turteltaub3 K.W., Garner R.C. The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure. Food Chem. Toxicol. 2004, 42:559-569.
10. Diehl K.H., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., Vidal J.M., van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 2001, 21:15-23.
11. Dietrich D.R., Heussner A.H., ÓBrien E. Ochratoxin A: comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans). Food. Addit. Contam 2005, 22(1):45-52.
12. EFSA Opinion of the scientific panel on contaminats in the food chain on a request from the commission related to the potential increase of consumer health risk by a possible increase of the existing maximun levels for aflatoxins in almonds, hazelnuts and pistachios and derived products. EFSA J. 2007, 446:1-127.
13. EFSA Opinion of the scientific panel on contaminats in the food chain on a request from the commision related to ochratoxin A in food. EFSA J. 2006, 365:1-56.
14. El-Khatib H.N., Akeila M.A., Abou El-magd M.K. The mutagenic activity of aflatoxin B1 in rat bone marrow. Toxicol. Lett. 1998, 95. 176-176.
15. Ellinger-Ziegelbauer H., Ahr H., Gmuender H., Pallez C., Koenig J. Characteristic expression profiles induced by carcinogens in rat liver. Toxicol. Lett. 2006, 164:S293-S294.
16. EC, 2002. Commission Regulation (EC) No 472/2002 of 12 March 2002 amending Regulation (EC) No 466/2001 setting maximum levels for certain contaminants in foodstuffs (Text with EEA relevance). L 75/18.
17. Firmin S., Gandia P., Morgavi D.P., Houin G., Jouany J.P., Bertin G., Boudra H. Modification of aflatoxin B1 and ochratoxin A toxicokinetics in rats administered a yeast cell wall preparation. Food Addit. Contam. 2010, 27:1153-1160.
18. Harvey R.B., Huff W.E., Kubena L.F., Phillips T.D. Evaluation of diets contaminated with aflatoxin and ochratoxin fed to growing pigs. Am. J. Vet. Res. 1989, 50:1400-1405.
19. Huff W.E., Kubena L.F., Harvey R.B., Phillips T.D. Efficacy of hydrated sodium calcium aluminosilicate to reduce the individual and combined toxicity of aflatoxin and ochratoxin A. Poult. Sci. 1992, 71:64-69.
20. Huff W.E., Kubena L.F., Harvey R.B., Doerr J.A. Mycotoxin interactions in poultry and swine. J. Anim. Sci. 1988, 66:2351-2355.
21. Huff W.E., Doerr J.A., Wabeck C.J., Chaloupka G.W., May J.D., Merkley J.W. Individual and combined effects of aflatoxin and ochratoxin A on bruising in broiler chickens. Poult. Sci. 1983, 62:1764-1771.
22. Huff W.E., Doerr J.A. Synergism between aflatoxin and ochratoxin A in broiler chickens. Poult. Sci. 1981, 60:550-555.
23. IARC, 2012. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans A Review of Human Carcinogens: Chemical Agents and Related Occupations. 100F.
24. IARC, 2002. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. 82, 590.
25. IARC, 1993. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. 56, 33.
26. ICH, 1994. Note for guidance of toxicokinetics: The assessment of systemic exposure in toxicity studies S3A. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
27. Jubert C., Mata J., Bench G., Dashwood R., Pereira C., Tracewell W., Turteltaub K., Williams D., Bailey G. Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B (1) pharmacokinetics in human volunteers. Cancer Prev. Res. 2009, 2(12):1015-1022.
28. Kuiper-Goodman T., Scott P.M. Risk assessment of the mycotoxin ochratoxin A. Biomed. Environ. Sci. 1989, 2:179-248.
29. Mally A., Dekant W. DNA adduct formation by ochratoxin A: review of the available evidence. Food Addit. Contam. 2005, 22(Suppl 1):65-74.
30. Mally A., Pepe G., Ravoori S., Fiore M., Gupta R.C., Dekant W., Mosesso P. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats. Chem. Res. Toxicol. 2005, 18:1253-1261.
31. Mally A., Zepnik H., Wanek P., Eder E., Dingley K., Ihmels H., Volkel W., Dekant W. Ochratoxin A: lack of formation of covalent DNA adducts. Chem. Res. Toxicol. 2004, 17:234-242.
32. Mantle P.G., Faucet-Marquis V., Manderville R.A., Squillaci B., Pfohl-Leszkowicz A. Structures of covalent adducts between DNA and ochratoxin a: a new factor in debate about genotoxicity and human risk assessment. Chem. Res. Toxicol. 2010, 23:89-98.
33. Mantle P.G. Interpretation of the pharmacokinetics of ochratoxin A in blood plasma of rats, during and after acute or chronic ingestion. Food Chem. Toxicol. 2008, 46:1808-1816.
34. Mantle P.G., Kulinskaya E., Nestler S. Renal tumourigenesis in male rats in response to chronic dietary ochratoxin A. Food Addit. Contam. 2005, 22(1):58-64.
35. Marin-Kuan M., Cavin C., Delatour T., Schilter B. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon 2008, 52:195-202.
36. McLean M., Dutton M.F. Cellular interactions and metabolism of aflatoxin: an update. Pharmac. Ther. 1995, 65:163-192.
37. Micco C., Miraglia M., Benelli L., Onori R., Ioppolo A., Mantovani A. Long term administration of low doses of mycotoxins in poultry. 2. Residues of ochratoxin A and aflatoxins in broilers and laying hens after combined administration of ochratoxin A and aflatoxin B1. Food Addit. Contam. 1988, 5:309-314.
38. NTP Toxicology and carcinogenesis studies of ochratoxin A (CAS No 303-47-9) in F344/N rats (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1989, 358:1-142.
39. O'Brien E., Dietrich D.R. Ochratoxin A: the Continuing Enigma. Crit. Rev. Toxicol. 2005, 35:33-60.
40. OECD, 2009. OECD Guidelines for the Testing of Chemicals. Draft proposal for a revised TG417: Toxicokinetics.
41. OECD, 1984. OECD Guidelines for the Testing of Chemicals, No. 417: Toxicokinetics.
42. Pfohl-Leszkowicz A., Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 2007, 51:61-99.
43. Pfohl-Leszkowicz A., Castegnaro M. Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit. Contam. 2005, 22(Suppl 1):75-87.
44. Raj H.G., Gupta K., Rohil V., Bose M., Biswas G., Singh S.K., Jain S.C., Parmar V.S., Olsen C.E., Wengel J. Aflatoxin B1-induced micronuclei and cell cycle alterations in lung and bone marrow cells and their modulation by Piper argyrophyllum extract. Teratog. Carcinog. Mutagen. 1998, 18:249-261.
45. Ramos A.J., Hernandez E. In situ absorption of aflatoxins in rat small intestine. Mycopathologia 1996, 134:27-30.
46. Rati E.R., Basappa S.C., Sreenivasa Murthy V., Ramesh H.P., Ramesh B.S., Singh G.B. The sinergistic effect of aflatoxin B1 and ochratoxin A in rats. J. Food Sci. Tech. 1981, 18:176-179.
47. Ringot D., Chango A., Schneider Y.J., Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem. Biol. Interact. 2006, 159:18-46.
48. Smela M.E., Hamm M.L., Henderson P.T., Harris C.M., Harris T.M., Essigmann J.M. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 2002, 99:6655-6660.
49. Smith G.S., Hall R.L., Walker R.M. Applied Clinical Pathology in Preclinical Toxicology Testing 2002, 123-156. Academic Press, San Diego.
50. Tapia M.O., Seawright A.A. Experimental combined aflatoxin B1 and ochratoxin A intoxication in pigs. Aust Vet. J. 1985, 62:33-37.
51. Theumer M.G., Cánepa M.C., López A.G., Mary V.S., Dambolena J.S., Rubinstein H.R. Subchronic mycotoxicoses in Wistar rats: assessment of the in vivo and in vitro genotoxicity induced by fumonisins and aflatoxin B1, and oxidative stress biomarkers status. Toxicology 2010, 268:104-110.
52. Turesky R.J. Perspective: ochratoxin A is not a genotoxic carcinogen. Chem. Res. Toxicol. 2005, 18:1082-1090.
53. Vettorazzi A., de Trocóniz I.F., González-Peñas E., Arbillaga L., Corcuera L., Gil A.G., López de Cerain A. Kidney and liver distribution of ochratoxin A in male and female F344 rats. Food Chem. Toxicol. 2011, 49:1935-1942.
54. Vettorazzi A., Trocóniz I.F., Gonzalez-Peñas E., Corcuera L.A., Arbillaga L., Gil A.G., Nagy J.M., Mantle P.G., López de Cerain A. Effects of fasting and gender on ochratoxin A toxicokinetics in F344 rats. Food Chem. Toxicol. 2010, 48:3159-3166.
55. Vettorazzi A., Gonzalez-Peñas E., Troconiz I.F., Arbillaga L., Corcuera L.A., Gil A.G., López de Cerain A. A different kinetic profile of ochratoxin A in mature male rats. Food Chem. Toxicol. 2009, 47:1921-1927.
56. Wangikar P.B., Dwivedi P., Sinha N., Sharma A.K., Telang A.G. Teratogenic effects in rabbits of simultaneous exposure to ochratoxin A and aflatoxin B1 with special reference to microscopic effects. Toxicology 2005, 215:37-47.
57. Wangikar P.B., Dwivedi P., Sinha N. Effect in rats of simultaneous prenatal exposure to ochratoxin A and aflatoxin B1. I. Maternal toxicity and fetal malformations. Birth defects research. Part B. Dev. Rep. Toxicol. 2004, 71:343-351.
58. WHO (World Health Organization), 2008. Safety evaluation of certain food additives and contaminants. WHO Food Additives Series, No. 59.
59. Wong Z.A., Hsieh D.P.H. The comparative metabolism and toxicokinetics of aflatoxin B1 in the monkey, rat, and mouse. Toxicol. Appl. Pharmacol. 1980, 55:115-125.
60. Zepnik H., Völkel W., Dekant W. Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration. Toxicol. Appl. Pharmacol. 2003, 192:36-44.